SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-21-000105
Filing Date
2021-11-04
Accepted
2021-11-04 16:06:10
Documents
48
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20210930.htm   iXBRL 10-Q 927436
2 EX-31.1 lfvn_093021xex311.htm EX-31.1 9737
3 EX-31.2 lfvn_093021xex312.htm EX-31.2 9708
4 EX-32.1 lfvn_093021xex321.htm EX-32.1 5044
5 EX-32.2 lfvn_093021xex322.htm EX-32.2 5015
  Complete submission text file 0000849146-21-000105.txt   4214108

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20210930.xsd EX-101.SCH 26872
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20210930_cal.xml EX-101.CAL 55899
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20210930_def.xml EX-101.DEF 104146
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20210930_lab.xml EX-101.LAB 415614
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20210930_pre.xml EX-101.PRE 240633
11 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20210930_htm.xml XML 535727
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 211379900
SIC: 2834 Pharmaceutical Preparations